Cortical Thickness Changes After Computerized Working Memory Training in Patients With Mild Cognitive Impairment.
dc.contributor.author | Hol, Haakon R | |
dc.contributor.author | Flak, Marianne M | |
dc.contributor.author | Chang, Linda | |
dc.contributor.author | Løhaugen, Gro Christine Christensen | |
dc.contributor.author | Bjuland, Knut Jørgen | |
dc.contributor.author | Rimol, Lars M | |
dc.contributor.author | Engvig, Andreas | |
dc.contributor.author | Skranes, Jon | |
dc.contributor.author | Ernst, Thomas | |
dc.contributor.author | Madsen, Bengt-Ove | |
dc.contributor.author | Hernes, Susanne S | |
dc.date.accessioned | 2022-04-25T11:36:20Z | |
dc.date.available | 2022-04-25T11:36:20Z | |
dc.date.issued | 2022-04-04 | |
dc.identifier.uri | http://hdl.handle.net/10713/18640 | |
dc.description.abstract | Magnetic resonance imaging acquisition at 1.5 T were performed at baseline, and after four- and 16-weeks post training. A total of 81 individuals with MCI accepted invitations to undergo 25 training sessions over 5 weeks. Longitudinal Linear Mixed effect models investigated the effect of adaptive vs. non-adaptive WM training. The LME model was fitted for each location (vertex). On all statistical analyzes, a threshold was applied to yield an expected false discovery rate (FDR) of 5%. A secondary LME model investigated the effects of LMX1A and APOE-ε4 on cortical thickness trajectories after WM training. | en_US |
dc.description.uri | https://doi.org/10.3389/fnagi.2022.796110 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Media S.A. | en_US |
dc.relation.ispartof | Frontiers in Aging Neuroscience | en_US |
dc.rights | Copyright © 2022 Hol, Flak, Chang, Løhaugen, Bjuland, Rimol, Engvig, Skranes, Ernst, Madsen and Hernes. | en_US |
dc.subject | APOE genotype | en_US |
dc.subject | LMX1A | en_US |
dc.subject | MCI | en_US |
dc.subject | cortical thickness | en_US |
dc.subject | working memory training | en_US |
dc.title | Cortical Thickness Changes After Computerized Working Memory Training in Patients With Mild Cognitive Impairment. | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.3389/fnagi.2022.796110 | |
dc.identifier.pmid | 35444526 | |
dc.source.journaltitle | Frontiers in aging neuroscience | |
dc.source.volume | 14 | |
dc.source.beginpage | 796110 | |
dc.source.endpage | ||
dc.source.country | Switzerland |